市場調查報告書
商品編碼
1401986
2030 年手術機器人市場預測:按組件、控制機制、應用、最終用戶和地區進行的全球分析Surgical Robots Market Forecasts to 2030 - Global Analysis By Component (Instruments & Accessory, Surgical System and Services), Control Mechanism, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球手術機器人市場規模將達43.1億美元,預計2030年將達到92.3億美元,複合年成長率為11.5%。
手術機器人是高科技設備,可以讓外科醫生以更高的精度、控制力和靈活性來執行各種外科手術。這些機器人被用於許多醫療領域,幫助完成困難的手術和微創手術。進行微創治療的能力是手術機器人的主要目標之一。這意味著與標準開放性手術相比,切口更小,創傷更小,恢復時間更快,對患者的影響可能更小。
據美國國家癌症研究所稱,到 2030 年,受癌症影響的人數預計將達到 2,200 萬,其中 60% 的病例預計發生在非洲、亞洲以及中美洲和南美洲。醫學診斷的進步使得癌症的檢測變得更加容易。因此,越來越多的患者選擇手術切除腫瘤。
擴大基於奈米技術的塗料的使用
隨著自動化機器人器械被涵蓋更多的外科手術中,對能夠支援和有效使用這些器械的先進機器人系統的需求日益成長。自主機器人工具的使用支持了微創手術的趨勢。這些器械允許進行微創手術,透過允許更小的切口和更精確的運動來減少患者的壓力和恢復時間。此外,製造商也致力於開發與自動化設備配合良好並針對自動化設備進行最佳化的機器人系統。因此,越來越複雜和多功能的機器人系統正在被製造出來。
初期成本高
對於許多醫療機構來說,開始使用手術機器人需要大量的初期成本,這被認為是困難的,特別是對於小型醫院和診所,或管理資源有限的機構。用於外科手術的機器人技術可能不會被採用,或者由於成本高昂而可能會被推遲。醫院和其他醫療機構在購買手術機器人之前會評估投資報酬率。尤其是在接受機器人輔助手術的患者數量不確定的情況下,一些機構因初期成本高、投資回報期長而望而卻步,阻礙了市場的成長。
擴大應用和外科專業
由於機器人系統融入了許多外科專業,醫療保健提供者擴大採用機器人系統。機器人輔助手術的優點,例如更高的精確度、更好的結果、更少的問題和更短的恢復時間,已被各個領域的外科醫生認知到,從而導致對該手術的接受和使用增加。手術機器人因其多功能性而受到廣泛歡迎,因為它們可以在不同的專業領域進行廣泛的治療,例如關節重建、子宮切除術、前列腺切除術、脊椎手術、心血管手術等,導致各種市場成長,創造了機會。
缺乏手術專業知識和標準化
不同設施和地區的培訓計劃不足可能會進一步阻礙機器人系統的普及。缺乏標準化程序和專業知識可能會影響手術機器人市場的成長。外科醫生、醫療機構和患者可能對結果的一致性和可預測性缺乏信心,可能會減緩機器人輔助手術的廣泛接受和採用。有效操作手術機器人所需的專業技能對於培訓工作人員和外科醫生來說可能是一個挑戰。
疫情期間,許多醫院和醫療機構延後或取消了擇期手術,包括使用手術機器人的手術。結果,機器人輔助手術減少,影響了市場擴張。儘管在大流行期間遇到了一些挫折,但微創手術因其有望縮短患者住院時間和結果而受到越來越多的關注。此外,機器人系統被認為可以以微創方式進行手術,從而吸引了更多的興趣和關注,並阻礙了市場的發展。
手術系統領域預計將在預測期內成為最大的領域
由於手術機器人市場包括各種手術系統,例如正在徹底改變手術領域的機器人輔助手術系統,因此手術機器人市場預計將出現良好的成長。與傳統方法相比,這些系統為外科醫生提供了微創治療過程中更高的精確度、靈活性和控制力。這些系統通常由採用先進技術的平台組成。某些手術技術允許外科醫生對位於偏遠地區的患者進行遠距臨場系統或遠端控制手術,這正在推動市場的成長。
心血管手術領域預計在預測期內複合年成長率最高
由於心血管手術使機器人輔助微創心血管手術治療(例如機器人輔助二尖瓣置換術和修復以及機器人輔助冠狀動脈繞道手術移植術(CABG))成為可能,因此在預測期內,心臟手術部分將達到最高水平。預計複合年成長率將成長。與心臟直視手術相比,這些方法對患者的創傷更小,需要的切口更少,並且恢復更快。由於機器人設備的卓越精度和靈活性,外科醫生現在可以更精確地進行複雜的心血管手術。
由於各種疾病的醫療設施和手術的進步,預計北美將在預測期內佔據最大的市場佔有率。對機器人輔助手術的需求正在增加,因為它比開放性手術提供更好的結果,並減少兒童的住院時間和復原時間。此外,隨著設備變得更小,應該可以在更小的空間內實現理想的工作條件,這將刺激市場擴張。
預計亞太地區在預測期內的複合年成長率最高。這是由於澳洲、中國、新加坡、印尼和印度的擴張導致快速成長。預計推動市場成長的另一個關鍵因素是旨在鼓勵醫療保健提供者和其他醫療保健組織利用技術先進的醫療設備和系統的政府計劃的增加。因此,所有上述因素都在推動市場成長。
According to Stratistics MRC, the Global Surgical Robots Market is accounted for $4.31 billion in 2023 and is expected to reach $9.23 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Surgical robots are high-tech devices that let surgeons operate more precisely, controllably, and deftly throughout a variety of surgical operations. These robots are used in many medical fields to help with difficult procedures and less invasive surgery. The ability to do treatments with minimum invasiveness is one of the main goals of surgical robots. This entails creating smaller incisions compared to standard open operations, leading to lower trauma, shorter recovery periods, and perhaps fewer consequences for patients
According to National Cancer Institute, the number of cancer incidences is estimated to reach 22 million by 2030; 60% of the cases are expected to occur in Africa, Asia, and Central & South American regions. With advancements in medical diagnostics, cancer detection has become easy. Thus, patients are now opting for surgical procedures to remove the tumor.
Expanding use of coatings based on nanotechnology
The market for surgical robots is growing and expanding as a result of the use of automated robotic tools and the need for sophisticated robotic systems that can support and efficiently use these tools is growing as automated robotic instruments are included into more surgical procedures. The trend toward less invasive surgery is supported by the use of autonomous robotic tools. These tools enable minimally invasive operations that lessen patient stress and recovery periods by enabling smaller incisions and more precise motions. Moreover, manufacturers concentrate on creating robotic systems that work well with automated equipment and are optimized for them. As a result, increasingly complex and versatile robotic systems are produced.
High initial costs
Many healthcare facilities find it difficult to get started using surgical robots because of the large upfront costs involved especially smaller hospitals, clinics, or those with limited resources. Robotic technology for surgical operations may not be adopted or may be adopted slowly due to the high price. Hospitals and other healthcare facilities assess the ROI before making a surgical robot purchase. Some institutions may be discouraged from making the investment because to the long ROI period caused by the high initial expenditures, particularly if they are unsure about the patient volume for robotically assisted procedures which hinder the growth of the market.
Expanded applications and surgical specialties
Healthcare providers are adopting robotic systems at an increasing rate as a result of their integration in many surgical specialties. The advantages of robotically assisted surgery, such as increased accuracy, better results, fewer problems, and quicker recovery periods, are acknowledged by surgeons from a variety of disciplines, which has led to increased acceptance and use of this technique. Surgical robots are in high demand because to their versatility in performing a wide range of treatments within different specialties, including joint replacements, hysterectomies, prostatectomies, spine surgeries, and cardiac procedures creating varied opportunities for the market growth.
Lack of surgical expertise and standardization
Insufficient training programs across different institutions or regions can further impede the widespread adoption of robotic systems. The lack of standardized procedures or expertise could impact the growth of the surgical robot market. Surgeons, healthcare institutions, and patients may not feel confident in the consistency and predictability of outcomes, which may slow the wider acceptance and adoption of robotic-assisted surgery. The specialized skills needed to operate surgical robots effectively can pose challenges for staff and surgeons undergoing training.
Many hospitals and healthcare institutions delayed or cancelled elective procedures, including those employing surgical robots, during the height of the epidemic. As a result, fewer surgeries using robot assistance were completed, which had an impact on the market's expansion. During the pandemic, despite some setbacks, there was an increasing focus on minimally invasive operations because of their promise to lower patient hospital stays and consequences. Moreover, the robotic systems have attracted more interest and attention since they are recognized to provide for least intrusive procedures thus hampering the market.
The surgical system segment is expected to be the largest during the forecast period
The surgical system segment is estimated to have a lucrative growth, owing to a range of surgical systems, including robotic-assisted surgical systems that are transforming the surgical sector, are included in the surgical robotics market. When compared to traditional approaches, these systems give enhanced precision, dexterity, and control to surgeons during minimally invasive treatments. They typically comprise of platforms with advanced technology. Surgeons can perform telepresence or remote-controlled surgery on patients from a distance due to certain surgical technologies which drive the growth of the market.
The cardiac surgery segment is expected to have the highest CAGR during the forecast period
The cardiac surgery segment is anticipated to witness the highest CAGR growth during the forecast period, because robot-assisted minimally invasive cardiac surgery treatments, such robot-assisted mitral valve replacement or repair and robot-assisted coronary artery bypass grafting (CABG), are made possible by surgical robots. Comparing these methods to open heart surgery, the patient experiences fewer traumas, requires fewer incisions, and recovers more quickly. Surgeons may now execute complex cardiac surgeries with increased accuracy because to robotic devices' exceptional precision and agility.
North America is projected to hold the largest market share during the forecast period owing to advancements in healthcare facilities and surgery for a range of illnesses. The demand for robotically assisted surgeries is increasing due to better results than open procedures and shorter hospital stays and recuperation times for children. Additionally, as instruments become smaller, it should be possible to achieve ideal working conditions in a smaller space, which would spur market expansion.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the increase at a rapid rate that is driven mostly by expansion in Australia, China, Singapore, Indonesia, and India. Another important factor anticipated to propel market growth is the increase in government programs aimed at encouraging healthcare providers and other healthcare organizations to utilize technologically advanced medical equipment & systems. Thus all the above factors drive the growth of the market.
Some of the key players profiled in the Surgical Robots Market include Medrobotics Corporation, Medtronic, Intuitive Surgical, Renishaw plc, THINK Surgical, Inc., Zimmer Biomet, Transenterix, Smith and Nephew, Stryker Corporation, Johnson & Johnson, Accuray Incorporated, CMR Surgical, Titan Medical Inc., Globus Medical, NuVasive Inc., Mazor Robotics, Auris Health Inc., Medineering GmbH, Preceyes BV and MicroSure
In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology.
In October 2023, Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest, The Aurora EV-ICD system is the first-of-its-kind to provide the life-saving benefits of traditional, transvenous ICDs.
In April 2023, Intuitive a global technology leader in minimally invasive care and pioneer of robotic-assisted surgery, announced that the Food and Drug Administration recently cleared the da Vinci SP surgical system